Hosted on MSN11mon
Penny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock Rallies
In July 2023, PaxMedica released topline data from PAX-HAT-301 Retrospective Analysis of Suramin Treatment for Stage 1 Trypanosoma Brucei Rhodesiense Human African Trypanosomiasis (S1 TBR HAT).
Discovery illuminates how sleeping sickness parasite outsmarts immune response
African sleeping sickness—also known as human African trypanosomiasis—is a neglected tropical disease that is usually fatal ...
ZAWYA4d
Mainstreaming Progressive Control Pathways for Animal Trypanosomiasis in Africa
Animal Trypanosomiasis remains a significant constraint to animal health and food security in most African countries. The ...
Nature1mon
How fieldwork transformed me from a doctor to a researcher
When I joined Guinea’s National Human African Trypanosomiasis (HAT) Control Programme in its Ministry of Health and Public Hygiene in 2013, all I knew about sleeping sickness was what I’d read ...